Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 244

Results For "IMI"

3829 News Found

Biocon enters commercialization agreement with Zentiva
News | November 24, 2022

Biocon enters commercialization agreement with Zentiva

Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe


Zydus receives final approval from USFDA for Famotidine Injection
News | November 24, 2022

Zydus receives final approval from USFDA for Famotidine Injection

Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed


BHL announces inauguration of Opium Processing Business at Savli
News | November 24, 2022

BHL announces inauguration of Opium Processing Business at Savli

The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications


Ajooni Biotech awarded ZED certification by Ministry of MSME
Biotech | November 22, 2022

Ajooni Biotech awarded ZED certification by Ministry of MSME

The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration


Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets
Drug Approval | November 22, 2022

Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets

Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022


Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system
Healthcare | November 22, 2022

Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system

LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes


Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr
News | November 22, 2022

Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr

The proceeds from this fund-raise will be deployed in financing the project requirements of the API business


Merck to acquire Imago BioSciences for $1.35 bn
News | November 22, 2022

Merck to acquire Imago BioSciences for $1.35 bn

Acquisition expands Merck’s growing hematology portfolio


USFDA completes pre-approval inspection of BHL's Vadodara facility
Drug Approval | November 21, 2022

USFDA completes pre-approval inspection of BHL's Vadodara facility

The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited


Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
Diagnostic Center | November 21, 2022

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster

Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data